Skip to content

BMC Pharmacology and Toxicology

ISSN 2050-6511

2 papers in the library · publishing 2012-2019

Papers

Sort Most recent Most cited

Differential role of dose and environment in initiating and intensifying neurotoxicity caused by MDMA in rats

BMC Pharmacology and Toxicology August 5, 2019 Ibrahim M. Shokry, Connor J. Shields, John J. Callanan et al.

Background MDMA causes serotonin (5-HT) syndrome immediately after administration and serotonergic injury in a few days or weeks. However, a serotonin syndrome is not always followed by serotonergic injury, indicating different mechanisms responsible for two adverse effects. The goal of present study was to determine causes for two adverse events and further test that dose and environment have...

The anti-addiction drug ibogaine inhibits cardiac ion channels: a study to assess the drug’s proarrhythmic potential

BMC Pharmacology and Toxicology September 1, 2012 Xaver Koenig, Michael Kovar, Lena Rubi et al.

The plant alkaloid ibogaine has shown promising anti-addictive properties in animals and humans. Although not licensed as a therapeutic drug, and despite evidence that ibogaine may disturb the rhythm of the heart, this alkaloid is used as an anti-addiction drug in alternative medicine. We have recently reported that therapeutic concentrations of ibogaine inhibit human ERG (hERG) potassium...